Search results for "Glioblast"

showing 10 items of 141 documents

Expression of Transketolase-like 1 and Activation of Akt in Grade IV Glioblastomas Compared With Grades II and III Astrocytic Gliomas

2008

Transketolases link the Embden-Meyerhof pathway to the pentose phosphate pathway. An influence of p-Akt on this metabolism was described. This study was performed to compare the expression of transketolase-like 1 (TKTL1) and p-Akt in glioblastoma multiforme (GBM) and other astrocytic gliomas (AGs, grades II and III). We analyzed 15 GBMs, 15 AGs (grade II), and 3 normal brain samples for TKTL1 expression by semiquantitative reverse transcription–polymerase chain reaction and Western blotting and 23 GBMs, 9 grade III AGs, and 7 grade II AGs immunohistochemically (TKTL1 and p-Akt). On the protein level, TKTL1 was significantly overexpressed in tumors. Immunohistochemically, the tumor grade sig…

Pathologymedicine.medical_specialtyAstrocytomaGeneral MedicineMetabolismAstrocytomaPentose phosphate pathwayTransketolaseBiologymedicine.diseaseEnzyme assayUp-RegulationEnzyme ActivationGene Expression Regulation NeoplasticBlotmedicinebiology.proteinCancer researchHumansGlycolysisRNA MessengerTransketolaseGlioblastomaProto-Oncogene Proteins c-aktProtein kinase BAmerican Journal of Clinical Pathology
researchProduct

Primary glioblastomas with and without EGFR amplification: Relationship to genetic alterations and clinicopathological features

2009

Glioblastomas express a notable heterogeneity in both the histological and cell patterns with glial astrocytic differentiation. Primary glioblastoma, which is the most frequent presentation (90-95%), occurs mainly in older patients and arises de novo, without any clinical or histological evidence of a less malignant precursor lesion. EGFR amplification has been identified as a genetic hallmark of primary glioblastomas and occurs in 40-60% of cases. However, there exist primary glioblastomas without EGFR amplification/overexpression. The purpose of this study was to stabilize the association between cases with and without EGFR gene amplification with clinical and genetic parameters in 45 cas…

Pathologymedicine.medical_specialtyEGFR AmplificationCellGeneral MedicineBiologyTp53 mutationmedicine.diseasePathology and Forensic Medicinemedicine.anatomical_structureOlder patientsCancer researchmedicinebiology.proteinClinicopathological featuresMdm2EGFR Gene AmplificationNeurology (clinical)neoplasmsGlioblastomaNeuropathology
researchProduct

Endothelial capillaries chemotactically attract tumour cells.

2001

Directional migration of capillaries towards tumour implants is generally assumed to be regulated by chemotaxis. Preliminary evidence has also been presented for the existence of a reverse chemotactic signalling pathway, with capillaries attracting tumour cells via paracrine factors. By using a variety of endothelial cell types and tumour cell lines, this study has systematically investigated chemotaxis between endothelial cells and tumour cells in two- and three-dimensional systems. Checkerboard analysis revealed faint attraction of human umbilical vein endothelial cells (HUVECs), but not porcine aortic endothelial cells (PAECs), by tumour cells. In reverse, both PAECs and HUVECs potently …

Pathologymedicine.medical_specialtyEndotheliumAngiogenesisSwineCell Culture TechniquesCell CommunicationBiologyPathology and Forensic MedicineParacrine signallingVasculogenesisNeoplasmsmedicineTumor Cells CulturedAnimalsHumansMicroscopy Phase-ContrastMelanomaFibrinNeovascularization PathologicChemotaxisMicrocarrierChemotaxisCell biologyCapillariesEndothelial stem cellmedicine.anatomical_structureCell cultureCulture Media Conditionedcardiovascular systemEndothelium VascularGlioblastomaThe Journal of pathology
researchProduct

T2 mapping of the peritumoral infiltration zone of glioblastoma and anaplastic astrocytoma.

2021

Purpose To characterise peritumoral zones in glioblastoma and anaplastic astrocytoma evaluating T2 values using T2 mapping sequences. Materials and methods In this study, 41 patients with histopathologically confirmed World Health Organization high grade gliomas and preoperative magnetic resonance imaging examinations were retrospectively identified and enrolled. High grade gliomas were differentiated: (a) by grade, glioblastoma versus anaplastic astrocytoma; and (b) by isocitrate dehydrogenase mutational state, mutated versus wildtype. T2 map relaxation times were assessed from the tumour centre to peritumoral zones by means of a region of interest and calculated pixelwise by using a fit m…

Pathologymedicine.medical_specialtyT2 mappingmultiparametric imagingAstrocytoma03 medical and health sciencesT2 mapping0302 clinical medicineGliomagliomamedicineHumansRadiology Nuclear Medicine and imagingneoplasmsRetrospective Studiesbusiness.industryBrain NeoplasmsMRI (magnetic resonance imaging)General MedicineOriginal Articlesmedicine.diseaseMagnetic Resonance ImagingIsocitrate DehydrogenaseMRI - Magnetic resonance imagingnervous system diseases030220 oncology & carcinogenesisMutationNeurology (clinical)businessGlioblastomaInfiltration (medical)030217 neurology & neurosurgeryGlioblastomaAnaplastic astrocytomaThe neuroradiology journal
researchProduct

Maximizing the Extent of Resection in High-Grade Glioma.

2019

High-grade gliomas (HGGs) are devastating tumors associated with one of the worst prognoses in oncology. Glioblastoma multiforme (GBM) is the most frequently reported histologic type, with a median survival after surgery and combined treatment with chemotherapy and radiotherapy of 12–16 months. Several studies have shown that the extent of resection (EOR) of the contrast-enhancing part of the tumor improves survival in patients with HGGs, although the quest to achieve optimal oncologic outcomes must be tempered with the neurologic result following radical resection. To date, limited evidence exists on the relationship between EOR and level of clinical benefit for patients with HGGs. Brown e…

Pathologymedicine.medical_specialtybusiness.industryBrain NeoplasmsOptical-fiberInfiltrationAuto fluorescenceBrainGliomaExtent of resectionmedicine.diseaseAuto-fluorescenceMedicineHumansSurgeryNeurology (clinical)GlioblastomabusinessInfiltration (medical)High-Grade GliomaGlioblastomaWorld neurosurgery
researchProduct

Up-regulation of cholesterol associated genes as novel resistance mechanism in glioblastoma cells in response to archazolid B

2014

Treatment of glioblastoma multiforme (GBM), the most common and aggressive lethal brain tumor, represents a great challenge. Despite decades of research, the survival prognosis of GBM patients is unfavorable and more effective therapeutics are sorely required. Archazolid B, a potent vacuolar H(+)-ATPase inhibitor influencing cellular pH values, is a promising new compound exerting cytotoxicity in the nanomolar range on wild-type U87MG glioblastoma cells and U87MG.∆EGFR cells transfected with a mutant epidermal growth factor receptor (EGFR) gene. Gene expression profiling using microarray technology showed that archazolid B caused drastic disturbances in cholesterol homeostasis. Cholesterol,…

PharmacologyCholesterolTransfectionBiologyToxicologyUp-RegulationSterol regulatory element-binding proteinGene expression profilingThiazoleschemistry.chemical_compoundCholesterolDownregulation and upregulationBiochemistrychemistryDrug Resistance NeoplasmCell Line TumorLDL receptorCancer researchbiology.proteinHumansV-ATPaselipids (amino acids peptides and proteins)MacrolidesEpidermal growth factor receptorGlioblastomaToxicology and Applied Pharmacology
researchProduct

The radiosensitization effect of titanate nanotubes as a new tool in radiation therapy for glioblastoma: A proof-of-concept

2013

Abstract Background and purpose One of the new challenges to improve radiotherapy is to increase the ionizing effect by using nanoparticles. The interest of titanate nanotubes (TiONts) associated with radiotherapy was evaluated in two human glioblastoma cell lines (SNB-19 and U87MG). Materials and methods Titanate nanotubes were synthetized by the hydrothermal treatment of titanium dioxide powder in a strongly basic NaOH solution. The cytotoxicity of TiONts was evaluated on SNB-19 and U87MG cell lines by cell proliferation assay. The internalization of TiONts was studied using Transmission Electron Microscopy (TEM). Finally, the effect of TiONts on cell radiosensitivity was evaluated using …

Radiation-Sensitizing AgentsCell SurvivalDNA repairCellApoptosisFlow cytometryCell Line TumormedicineHumansRadiology Nuclear Medicine and imagingRadiosensitivityClonogenic assayCytotoxicityTitaniumNanotubesmedicine.diagnostic_testBrain NeoplasmsChemistryCell growthCell CycleHematologyCell cyclemedicine.anatomical_structureOncologyBiophysicsGlioblastomaReactive Oxygen SpeciesDNA DamageRadiotherapy and Oncology
researchProduct

A radiosensitizing effect of artesunate in glioblastoma cells is associated with a diminished expression of the inhibitor of apoptosis protein surviv…

2011

Abstract Background and purpose Novel strategies to overcome an irradiation resistant phenotype may help to increase therapeutic efficacy in glioblastoma multiforme. The present study aimed to elucidate radiation sensitizing properties of artesunate, a semi synthetic derivate of artemisinin and to assess factors involved in this effect. Materials and methods LN229 and U87MG cells were treated with various concentrations of artesunate and radiation response was determined by a colony forming assay. Cell numbers, apoptosis induction, cell cycle distribution, and DNA repair following combined modality treatment were monitored by MTT-, caspase 3/7 assay, cytofluorometry, and γ-H2AX foci formati…

Radiation-Sensitizing AgentsDNA RepairCell SurvivalSurvivinArtesunateDown-RegulationCaspase 3ApoptosisInhibitor of apoptosisInhibitor of Apoptosis Proteinschemistry.chemical_compoundCell Line TumorSurvivinHumansRadiology Nuclear Medicine and imagingClonogenic assayDose-Response Relationship DrugBrain NeoplasmsCell CycleHematologyCell cycleArtemisininsXIAPNeoplasm ProteinsOncologychemistryArtesunateApoptosisCancer researchGlioblastomaRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
researchProduct

Integrated approach to delineating molecular traits of recurrent glioblastoma using glioma stem cell models and tumor tissue profiling

2018

Recurrent glioblastomaGliomamedicineCancer researchProfiling (information science)BiologyIntegrated approachStem cellmedicine.diseaseTumor tissue27th Annual Meeting of the working group “Experimental Neuro-Oncology”
researchProduct

Case of multifocal glioblastoma with four fusion transcripts of ALK, FGFR2, NTRK2, and NTRK3 genes stresses the need for tumor tissue multisampling f…

2021

Glioblastoma multiforme (GBM) is the most malignant brain tumor with patient mortality rate close to 100%, 5-yr survival rate of ∼5%, and a median survival of 14 mo. GBMs have notorious histomorphologic and molecular heterogeneities thus giving hope for development of future personalized therapies. We describe here a case of a 48-yr-old male patient with three-nodular GBM. To address the question of intratumoral molecular heterogeneity, a comparative analysis of gene expression was performed by using multiple samples collected from different tumor sites with the aid of intraoperative magnetic resonance imaging (MRI). Sixteen GBM biosamples from parietal, temporal, and temporo-polar localiza…

Research ReportMaleTemozolomideOncogene Proteins FusionBevacizumabBrain NeoplasmsglioblastomaRNAOncogenesGeneral MedicineMiddle AgedBiologyMagnetic Resonance ImagingTranscriptomeFusion transcriptGene expressionCancer researchmedicineHumansTranscriptomeGeneSurvival rateneoplasm of the central nervous systemmedicine.drugMolecular Case Studies
researchProduct